PubHawk
N Engl J Med December 2020 PMID 33264825

Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes.

George L Bakris, Rajiv Agarwal, Stefan D Anker, Bertram Pitt, Luis M Ruilope, Peter Rossing, Peter Kolkhof, Christina Nowack, Patrick Schloemer, Amer Joseph, Gerasimos Filippatos

Download social card

Mentions

413
Peak: 54 in Mar 2025
across 6 sources since Oct 2020

Extended reach

1,046,341
potential audience

Total likes

715

Video views

19,953

Mentions per month

Oct 2020 – Aug 2025

Where it's discussed

  • X / Twitter286 posts
  • News104 articles
  • Facebook8 posts
  • Blogs8 articles
  • YouTube4 videos
  • Bluesky3 posts

AI synopsis

What people are saying

The discussions highlight the efficacy of finerenone by referencing results from clinical trials like FIDELIO-DKD, where it showed a reduction in kidney-related complications. Phrases like 'game changer' and notes of excitement about significant impacts on patient health capture the overall positive sentiment. Additionally, detailed conversations around specific data points, such as reduced event rates and comparisons with other treatments, emphasize a well-informed and passionate community responding to this pivotal research.

AgreementStrong agreement

The majority of discussions express a strong consensus on the positive outcomes of finerenone in treating patients with chronic kidney disease and type 2 diabetes.

InterestHigh interest

Posts reflect high levels of curiosity about finerenone, citing specific studies and results, indicating its relevance to ongoing conversations in the medical community.

EngagementHigh engagement

Participants actively engage with the findings by discussing trials, methodological details, and implications for clinical practice, demonstrating deep involvement in the topic.

ImpactHigh impact

Many users perceive the publication as having significant implications for treatment approaches in nephrology, evidenced by mentions of reduced risks for important health outcomes.

Abstract in brief

  • Finerenone, a new medication for managing chronic kidney disease (CKD) in patients with type 2 diabetes, showed a significant reduction in kidney-related complications compared to a placebo in a large double-blind trial with over 5,700 participants.
  • The study found that patients taking finerenone experienced fewer primary outcome events (kidney failure and related issues) with a 17.8% incidence compared to 21.1% in the placebo group, indicating its effectiveness with a hazard ratio of 0.82.
  • Additionally, finerenone also demonstrated a beneficial effect on cardiovascular outcomes, with a reduction in events such as heart attacks and strokes compared to the placebo group, suggesting its potential for broader health benefits beyond kidney protection.
Read the full abstract

Top posts

Most liked on X and Bluesky
Edgar V. Lerma
@edgarvlermamd · X

Effect of Finerenone on CKD Outcomes in Type 2 Diabetes ca. 2020 from @NEJM @AgarwalRajivMD @BakrisGeorge #Nephpearls #VisualAbstract by @whatsthegfr https://t.co/FnhY0qQCi6 https://t.co/9DfF2hn1xH

Jul 10, 2021 · 36 likes · 11 shares · 33,564 followers View post →
ACCP Cardiology PRN
@accpcardprn · X

For today's #WhatsNewWednesday let’s take a

Apr 6, 2022 · 30 likes · 6 shares · 9,300 followers View post →
Edgar V. Lerma
@edgarvlermamd · X

Effect of Finerenone on CKD Outcomes in Type 2 Diabetes ca. 2020 from @NEJM @AgarwalRajivMD @BakrisGeorge #Nephpearls #VisualAbstract by @whatsthegfr https://t.co/FnhY0qQCi6 https://t.co/wyMS6AyHF3 https://t.co/OeCN7QuhS5

Jul 10, 2021 · 16 likes · 6 shares · 33,564 followers View post →
Ashwasena (अश्‍वसेन)
@Renaltubules · X

Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes https://t.co/J7qejds95X

Oct 24, 2020 · 13 likes · 1 share · 7,532 followers View post →
Kimitaka Nishizaki
@nishiki8885 · X

大山先生 @kazuma_oyama より FinerenoneはほかのMRAに比べて ✔︎ MR拮抗作用が強い ✔︎ 心臓への作用が相対的に大きい ✔︎ 抗線維化作用が大きい

Nov 13, 2021 · 13 likes · 5 shares · 2,947 followers View post →
Int Society of Nephrology
@ISNkidneycare · X

Live now: Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes (FIDELIO-DKD): George Bakris, MD, on behalf of the FIDELIO Executive Committee and International investigator teams Follow our coverage through this thread.... #ISNwebinar @BakrisGeorge https://t.co/HjUIOJvrKM

Dec 16, 2020 · 12 likes · 1 share · 29,175 followers View post →

All mentions

Marco Anaya_NefroX
@Nefrotweet · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Aug 26, 2025 · 178 shares · 1,746 followers View post →
Mohamed E. Elrggal
@M_Elraggal · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Aug 26, 2025 · 178 shares · 1,699 followers View post →
Ahmed Serageldeen
@ahmed_shaban_s · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Aug 26, 2025 · 178 shares · 223 followers View post →
Roberto Gutiérrez
@DrRobertoGuti · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Jun 9, 2025 · 178 shares · 782 followers View post →
NephroLOGY BOX. GUO's
@ulusalokyay · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Jun 9, 2025 · 178 shares · 169 followers View post →
diacavan
@diacavan · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Jun 8, 2025 · 178 shares · 165 followers View post →
Karo Vivanco✌
@Karovivanco29 · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Jun 8, 2025 · 178 shares · 933 followers View post →
Magaly Abarca Pineda
@Magalyabarca · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Jun 8, 2025 · 178 shares · 248 followers View post →
Vademon24292
@CarlosA09557330 · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Jun 8, 2025 · 178 shares · 520 followers View post →
Erik on the Run
@Erik_RB16b · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Jun 8, 2025 · 178 shares · 333 followers View post →
Franklin Loachamin
@FranLoachamin · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Jun 8, 2025 · 178 shares · 4,889 followers View post →
Nep
@HadiMD_ · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Jun 8, 2025 · 178 shares · 351 followers View post →
Milagros Flores
@dra_miliflores · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Jun 8, 2025 · 178 shares · 914 followers View post →
nyiminhan
@nyiminhan · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Jun 7, 2025 · 178 shares · 545 followers View post →
د علي السهو FRCPC, FASN, FISN
@alialsahow · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Jun 7, 2025 · 178 shares · 2,064 followers View post →
Manuel Gaxiola
@cardiogax · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Jun 6, 2025 · 178 shares · 7,990 followers View post →
Mohammad Aleidi
@aleidimed · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Jun 6, 2025 · 178 shares · 298 followers View post →
marc0
@markosycc · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Jun 6, 2025 · 178 shares · 20 followers View post →
Edson Makambwa
@EdsonMakambwa · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Jun 6, 2025 · 178 shares · 41 followers View post →
KittyKat555
@KatieSh74387435 · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Mar 29, 2025 · 178 shares · 948 followers View post →
TISOYMD
@TisoyMDSays · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Mar 23, 2025 · 178 shares · 694 followers View post →
Johanna Calib Macataman
@itsjohannacm · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Mar 21, 2025 · 178 shares · 23 followers View post →
Nefrología UMAE 71
@NefroUmae71 · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Mar 17, 2025 · 178 shares · 191 followers View post →
Sayed S. Rahman
@SayedSRahman1 · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Mar 16, 2025 · 178 shares · 151 followers View post →
Jez Chua
@jezchuamd · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Mar 6, 2025 · 178 shares · 11 followers View post →
Pedro Betancourt
@Pedrob251 · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Mar 5, 2025 · 178 shares · 1,829 followers View post →
Clinical cardiology
@Mahmoud33986639 · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Mar 4, 2025 · 178 shares · 250 followers View post →
Dr. Ambily K
@drambilyk · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Mar 3, 2025 · 178 shares · 312 followers View post →
Irving Trejo Curiel
@irvtc · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Mar 3, 2025 · 178 shares · 33 followers View post →
Koushik Chakma
@Koushikchak2013 · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Mar 3, 2025 · 178 shares · 8 followers View post →
Bhavya dasara
@bhavya_dasara · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Mar 2, 2025 · 178 shares · 791 followers View post →
MariGeli
@yo32185 · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Mar 2, 2025 · 178 shares · 33 followers View post →
José Luiz
@nefrotweets · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Mar 2, 2025 · 178 shares · 96 followers View post →
Nefrología HRLALM
@NefroHRLALM · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Mar 2, 2025 · 178 shares · 210 followers View post →
Ale Padron
@nefroalejapatch · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Mar 2, 2025 · 178 shares · 50 followers View post →
EmmaHuang
@EmmaHuang81 · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Mar 2, 2025 · 178 shares · 92 followers View post →
Dr.Trauma_Do
@Dr_Trauma_do · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Mar 1, 2025 · 178 shares · 43 followers View post →
Alina Martin
@alinamartin811 · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Mar 1, 2025 · 178 shares · 8 followers View post →
Natsir Ramadhan
@natsiradhan · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Mar 1, 2025 · 178 shares · 560 followers View post →
Ibn Aris
@ibenzimidazole · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Mar 1, 2025 · 178 shares · 945 followers View post →
Nefrologo Roman Hernandez Rios
@NefroRomanHdez · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Mar 1, 2025 · 178 shares · 443 followers View post →
Alexandro Franco Estrada
@AlexEstradaF · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Mar 1, 2025 · 178 shares · 106 followers View post →
Dr. No
@DRCRITICALCARE3 · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Mar 1, 2025 · 178 shares · 481 followers View post →
Goaty 2 am
@OGoaty5 · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Mar 1, 2025 · 178 shares · 494 followers View post →
Sara Almutar
@s_almutar · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Mar 1, 2025 · 178 shares · 1,568 followers View post →
Dr. Carlos Orellana
@orellanamd · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Mar 1, 2025 · 178 shares · 551 followers View post →
Ppp
@Pingg_niP · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Mar 1, 2025 · 178 shares · 395 followers View post →
Laura Pérez
@tatana2007 · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Mar 1, 2025 · 178 shares · 238 followers View post →
Carmela Ramos
@carmelanefro · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Mar 1, 2025 · 178 shares · 6 followers View post →
Oscar
@OscarAlfredoLu4 · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Mar 1, 2025 · 178 shares · 192 followers View post →
M. Azman Pasha
@PandAzman · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Mar 1, 2025 · 178 shares · 617 followers View post →
Juan Santiago
@JohnLMJ · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Mar 1, 2025 · 178 shares · 367 followers View post →
Sam
@spanday31 · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Mar 1, 2025 · 178 shares · 280 followers View post →
diacavan
@diacavan · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Mar 1, 2025 · 178 shares · 165 followers View post →
Julio César
@DrJulioMatuteM · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Mar 1, 2025 · 178 shares · 1,424 followers View post →
Marcello Di Zenzo
@ZenzoMarcello · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Mar 1, 2025 · 178 shares · 71 followers View post →
Aarthi Muthukumaran
@aarthi_dr · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Mar 1, 2025 · 178 shares · 1,542 followers View post →
Luis Ribeiro
@ribeiro_queiros · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Mar 1, 2025 · 178 shares · 144 followers View post →
Vincci Monique Salud, M.D.
@moniquecularMD · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Mar 1, 2025 · 178 shares · 85 followers View post →
Takuya Kishi @ねこ好き循環器内科医
@tkishi_cardiol · X

RT @drbennisahmed: Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes In patients with CKD and type 2 diabetes, tr…

Mar 1, 2025 · 2 shares · 14,688 followers View post →
M Azfar Qureshi
@MAQ_Renal · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Mar 1, 2025 · 178 shares · 164 followers View post →
Ahmed Bennis MD
@drbennisahmed · X

Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes In patients with CKD and type 2 diabetes, treatment with finerenone resulted in lower risks of CKD progression and cardiovascular events than placebo https://t.co/eoiMI1BgHq https://t.co/5UjMkGwC3O

Mar 1, 2025 · 8 likes · 2 shares · 2,659 followers View post →
Estefanía Argüello
@tefitasaloata · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Mar 1, 2025 · 178 shares · 15 followers View post →
Namesh kamat
@namesh217 · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Mar 1, 2025 · 178 shares · 244 followers View post →
MedEd Global Solutions
@global_meded · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Mar 1, 2025 · 178 shares · 244 followers View post →
Victor Hernández
@VicHdez27 · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Mar 1, 2025 · 178 shares · 140 followers View post →
Mike Tenckhoff
@miguel_mgtz7 · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Mar 1, 2025 · 178 shares · 515 followers View post →
Manika Adari
@ManikaAdari · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Mar 1, 2025 · 178 shares · 20 followers View post →
GHAZALI, M.D
@MGhazali225 · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Mar 1, 2025 · 178 shares · 157 followers View post →
Emmanuel Bailon
@2807Mababa · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Mar 1, 2025 · 178 shares · 19 followers View post →
Caps, MD
@Caaaapslock_ · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Mar 1, 2025 · 178 shares · 599 followers View post →
Diana Zambri
@dianitazambri · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Mar 1, 2025 · 178 shares · 170 followers View post →
Abc
@abraham_0699 · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Mar 1, 2025 · 178 shares · 20 followers View post →
Mayra Avilés
@marsdance21 · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Feb 28, 2025 · 178 shares · 296 followers View post →
S.Runprapan
@wwanderlusterr · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Feb 28, 2025 · 178 shares · 48 followers View post →
Cristhian Muñoz
@CristhianMuM · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Feb 28, 2025 · 178 shares · 952 followers View post →
Armando Morales S.
@amsnefrologo · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Feb 28, 2025 · 178 shares · 19 followers View post →
Cardiogrumpy
@Khabelo · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Feb 28, 2025 · 178 shares · 265 followers View post →
Spandana Ravada Vora
@spandanaravada · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Feb 28, 2025 · 178 shares · 178 followers View post →
Dr Theepa N.M.R
@TNesam · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Feb 28, 2025 · 178 shares · 698 followers View post →
Joyce Bwombengi
@kemuntoMD · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Feb 28, 2025 · 178 shares · 1,082 followers View post →
そらまめ医
@YiSoramame · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Feb 28, 2025 · 178 shares · 442 followers View post →
refntokyo
@tokyo_Oli_drift · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Feb 28, 2025 · 178 shares · 274 followers View post →
Brian Ricardo Garibay Vega
@BrianGaribayV · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Feb 28, 2025 · 178 shares · 101 followers View post →
Pawan Rao MD, FASN
@nephronus · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Feb 28, 2025 · 178 shares · 997 followers View post →
Prawesh Adhikari
@PraweshAdhikar1 · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Feb 28, 2025 · 178 shares · 25 followers View post →
CLEO
@CleoKrg · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Feb 28, 2025 · 178 shares · 39 followers View post →
Alsun Cabarles
@HarriZoon · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Feb 28, 2025 · 178 shares · 125 followers View post →
EOLO MORANDI JR.
@eolojr · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Feb 28, 2025 · 178 shares · 539 followers View post →
rubensg.
@un_rubens · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Feb 28, 2025 · 178 shares · 226 followers View post →
Aurora Beatriz Tutiven Ubilla
@AuroraTutiven · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Feb 28, 2025 · 178 shares · 199 followers View post →
Nader
@Nader62321135 · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Feb 28, 2025 · 178 shares · 85 followers View post →
Nefrología CMN SXXI
@NefroCMNSXXI · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Feb 28, 2025 · 178 shares · 1,182 followers View post →
Ken Lim, MD PhD
@TheLimLab · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Feb 28, 2025 · 178 shares · 277 followers View post →
Elías
@ElasV05 · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Feb 28, 2025 · 178 shares · 104 followers View post →
Umut Kocabaş
@UmutKocabasMD · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Feb 28, 2025 · 178 shares · 1,459 followers View post →
Muthu Vaduganathan
@mvaduganathan · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Feb 28, 2025 · 178 shares · 9,163 followers View post →
Dr NAGA SHASHIKANTH P
@NagaShashikanth · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Feb 28, 2025 · 178 shares · 75 followers View post →
Almansour
@malmansour81 · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Feb 28, 2025 · 178 shares · 210 followers View post →
Clemente Porras
@Memeporras · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Feb 28, 2025 · 178 shares · 78 followers View post →
Lamri Aldjia
@AldjiaLamri · X

RT @edgarvlermamd: Finerenone trials #PSHPLAS

Feb 28, 2025 · 178 shares · 141 followers View post →
Edgar V. Lerma
@edgarvlermamd.bsky.social · Bluesky

Finerenone trials #PSHPLAS

Feb 28, 2025 · 11 likes · 5 shares View post →
キャンプ剤師【循腎児】
@zaishicamp · X

ns-MRA FIDELIO-DKD https://t.co/bRLyi19N9g

Jan 24, 2025 · 202 followers View post →
Sri Lekha Tummalapalli, MD, MBA
@LTummalapalli · X

@amitksvs References here: CREDENCE: https://t.co/HKhHT9kFqp FIDELIO-DKD: https://t.co/dXu1ZlqTjM SONAR: https://t.co/ELyfrCc3cD FLOW: https://t.co/qTVwBT392F

Oct 25, 2024 · 2,317 followers View post →
Jose De La Flor
@josedelaflor4 · X

RT @NephJC: Evidence on efficacy

May 23, 2024 · 1 share · 456 followers View post →
Nephrology Journal Club
@NephJC · X

Evidence on efficacy

May 22, 2024 · 5 likes · 1 share · 38,254 followers View post →
Nephrology Journal Club
@NephJC · X

Evidence on efficacy

May 21, 2024 · 4 likes · 38,254 followers View post →
Cristobal Morales
@CristobMorales · X

RT @GoggleDocs: 18) Does Finenerone improves kidney outcomes❓

Apr 24, 2024 · 1 share · 17,051 followers View post →
GoggleDocs
@GoggleDocs · X

18) Does Finenerone improves kidney outcomes❓

Apr 24, 2024 · 5 likes · 1 share · 3,654 followers View post →
Finerenona España
@KerendiaEsp · X

RT @kidney_boy: @Xfan852266 Everyone in the Fidelio trial was on either an ACEi or ARB at maximally tolerated dose, and while hyperkalemia…

Jan 22, 2024 · 1 share · 233 followers View post →
Joel M. Topf, MD FACP
@kidney_boy · X

@Xfan852266 Everyone in the Fidelio trial was on either an ACEi or ARB at maximally tolerated dose, and while hyperkalemia was an important adverse event, mortality was lower with finerenone compared to placebo. https://t.co/MdVHnH7JkP https://t.co/uNYMUChFOl

Jan 20, 2024 · 4 likes · 1 share · 63,282 followers View post →
YD_AUSTRIA
@YD_AUT · X

Link zum Volltext: https://t.co/BgNrITKNJ2

Sep 27, 2023 · 3 likes · 105 followers View post →
Alex Smith
@AlexTSmithNY · X

@JasBajwa18 Any thoughts about adding finerenone to this mix? https://t.co/YRqHF1siJe

Sep 17, 2023 · 1 like · 289 followers View post →
にいやん
@niiyan51 · X

Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes https://t.co/nxMKd25cn4

Jul 11, 2023 · 1,074 followers View post →
Juan Pablo Flores
@JuanPablo_Fs · X

RT @JonathanNefro: En pacientes con DIABETES y enfermedad RENAL CRÓNICA G3bA3, FINERENONA redujo 18% el evento renal compuesto y 14% los ev…

Jun 19, 2023 · 12 shares · 152 followers View post →
cardio-met
@cardiomet_CE · X

32) #FIDELIODKD & #FIGARODKD included subgroup analyses in younger v older individuals, hidden in supplements or follow up pubs

Jun 7, 2023 · 4,157 followers View post →
Leo Washizawa
@Leo_Washizawa · X

RAS阻害薬に加えてミネラルコルチコイド受容体阻害薬(MRB)はCKD患者の進行を抑制する効果がある。これはMRBによる抗炎症や抗繊維化作用と関連していることを示唆する論文 https://t.co/w61P0AvXyU

May 31, 2023 · 46 followers View post →
@CKD_ce
@ckd_ce · X

32) #FIDELIODKD & #FIGARODKD included subgroup analyses in younger v older individuals, hidden in supplements or follow up pubs

May 25, 2023 · 1 like · 2,636 followers View post →
Abhishek
@aksrulz13 · X

RT @FirketLouis: 16/ What about the efficacy in CKD ? Currently, the strongest data comes from FIDELIO-DKD trial in 2020:

Mar 27, 2023 · 1 share · 622 followers View post →
Louis Firket
@FirketLouis · X

16/ What about the efficacy in CKD ? Currently, the strongest data comes from FIDELIO-DKD trial in 2020:

Mar 25, 2023 · 4 likes · 1 share · 267 followers View post →
Dipòsit Digital UB
@DD_UB · X

Effect of Finerenone on chronic kidney disease outcomes in type 2 diabetes https://t.co/SdMFgJHMSx

Mar 22, 2023 · 488 followers View post →
Pharmacy Residency
@Phresidency · X

We enjoyed today our Pharmacy Grand Round Lecture titled “Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes” presented by Dr. Aliyah Alorayyidh, R2 Pharmacy Resident https://t.co/VIRXRS1PQz

Mar 16, 2023 · 1 like · 1,646 followers View post →
cardio-met
@cardiomet_CE · X

37) A new kid on the block is #finerenone, a #nonsteroidal and selective #MRA. Data from #FIDELIO-DKD showed that it: -⬇️primary composite renal outcomes -⬇️sustained decrease in eGFR -⬇️secondary composite CV outcomes

Mar 15, 2023 · 2 likes · 4,157 followers View post →
Thrace Element
@ThracianCylon · X

@Yalcinsolak4 NNT'si 30. Yani 1 kişide composite outcome'ı engellemek için 30 kişiye vermemiz gerekiyor. 1 kişide Böbrek yetmezliğini engellemek için 100 kişiye vermek gerekiyor. :-) https://t.co/Y4StJXzboc

Jan 17, 2023 · 786 followers View post →
Yash
@DoctorBhavsar · X

@SeeFisch Thanks for the info Doc ! Got this article as a reference. https://t.co/F6Ryya2pjn

Jan 17, 2023 · 8 likes · 3,849 followers View post →
@CKD_ce
@ckd_ce · X

37) A new kid on the block is #finerenone, a #nonsteroidal and selective #MRA. Data from #FIDELIO-DKD showed that it: -⬇️primary composite renal outcomes -⬇️sustained decrease in eGFR -⬇️secondary composite CV outcomes

Jan 11, 2023 · 2 likes · 2,636 followers View post →
Rosina Dal Maso
@MasoRosina · X

RT @kidney_boy: In Fidelio there were two doses of finerenone, 10 mg and 20 mg. Though the study started with people at GFRE< 60 on 10 mg,…

Jan 3, 2023 · 2 shares · 57 followers View post →
soda_troubles,https://med-mastodon.com/@haysam
@set_fortess · X

RT @kidney_boy: In Fidelio there were two doses of finerenone, 10 mg and 20 mg. Though the study started with people at GFRE< 60 on 10 mg,…

Jan 2, 2023 · 2 shares · 2,546 followers View post →
Joel Topf
@kidneyboy.bsky.social · Bluesky

mEq/L. https://www.nejm.org/doi/full/10.1056/NEJMoa2025845

Jan 2, 2023 · 1 share View post →
Joel M. Topf, MD FACP
@kidney_boy · X

In Fidelio there were two doses of finerenone, 10 mg and 20 mg. Though the study started with people at GFRE< 60 on 10 mg, the protocol aggressively raised the dose to 20 mg and would not lower it if the potassium was as high as 5.5 mEq/L. https://t.co/MdVHnH7JkP https://t.co/pcErjWV4Yg

Jan 2, 2023 · 9 likes · 2 shares · 63,282 followers View post →
Sophia Ambruso
@sophia_kidney · X

RT @ckd_ce: 38) #FIDELIO-DKD, #RCT of finerenone vs placebo in CKD outcomes in #T2D vs placebo. Primary outcome: kidney failure, sustained…

Dec 14, 2022 · 3 shares · 1,973 followers View post →
Manu Morales Sánchez
@Manugrillo2 · X

RT @ckd_ce: 38) #FIDELIO-DKD, #RCT of finerenone vs placebo in CKD outcomes in #T2D vs placebo. Primary outcome: kidney failure, sustained…

Dec 14, 2022 · 3 shares · 2,140 followers View post →
Finerenona España
@KerendiaEsp · X

RT @ckd_ce: 38) #FIDELIO-DKD, #RCT of finerenone vs placebo in CKD outcomes in #T2D vs placebo. Primary outcome: kidney failure, sustained…

Dec 14, 2022 · 3 shares · 233 followers View post →
@CKD_ce
@ckd_ce · X

38) #FIDELIO-DKD, #RCT of finerenone vs placebo in CKD outcomes in #T2D vs placebo. Primary outcome: kidney failure, sustained eGFR decrease > 40% or death from any renal cause, N = 5674, favored finerenone, 17.8% event rate vs 21.1% w/placebo

Dec 14, 2022 · 3 likes · 3 shares · 2,636 followers View post →
Abhishek
@aksrulz13 · X

RT @drdschwartzmd: 1st study to show in CKD and T2D pts, tx with finerenone (a nonsteroidal, selective mineralocorticoid receptor antagonis…

Dec 2, 2022 · 1 share · 622 followers View post →
Abhishek
@aksrulz13 · X

RT @drdschwartzmd: 6) FIDELIO: Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes While MRAs, including finerenone…

Dec 2, 2022 · 1 share · 622 followers View post →
Daniel Schwartz, MD
@drdschwartzmd · X

1st study to show in CKD and T2D pts, tx with finerenone (a nonsteroidal, selective mineralocorticoid receptor antagonist) led to lower risks of CKD progression and CV events than placebo. https://t.co/VfrbUsPqB8

Dec 2, 2022 · 6 likes · 1 share · 1,086 followers View post →
Daniel Schwartz, MD
@drdschwartzmd · X

6) FIDELIO: Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes While MRAs, including finerenone shown to reduce albuminuria in short-term trials, long-term benefits on kidney and cardiovascular outcomes were unknown @BakrisGeorge https://t.co/V1E6MWqyLf

Dec 2, 2022 · 4 likes · 1 share · 1,086 followers View post →
Daniel Schwartz, MD
@drdschwartzmd · X

Finerenone was studied in FIDELIO and FIGARO & enrolled when SGLT2i were not yet standard care https://t.co/VA1VwHO0AO https://t.co/WsR99nPP06

Nov 29, 2022 · 2 likes · 1,086 followers View post →
Sundar Sankaran
@sundar_s1955 · X

Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes | NEJM https://t.co/TT2GzAlq32

Oct 28, 2022 · 8,810 followers View post →
La cocina del diabetico
@DiabeticoLa · X

Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes | NEJM – https://t.co/YsznrSSmMM https://t.co/BPbOyjEUZk

Oct 24, 2022 · 5 followers View post →
Rosa Tomás
@rosa_tomas · X

Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes | NEJM https://t.co/1gZzggy9r4

Oct 10, 2022 · 6,977 followers View post →
Jose Carlos Arevalo
@joscarlor2 · X

RT @KerendiaEsp: Episode 028: Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes. #finerenone #finerenona https://…

Aug 12, 2022 · 3 shares · 759 followers View post →
Manu Morales Sánchez
@Manugrillo2 · X

RT @KerendiaEsp: Episode 028: Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes. #finerenone #finerenona https://…

Aug 12, 2022 · 3 shares · 2,140 followers View post →
Finerenona España
@KerendiaEsp · X

Episode 028: Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes. #finerenone #finerenona https://t.co/ZcHoNEEee6

Aug 11, 2022 · 3 likes · 3 shares · 233 followers View post →
ぽん@
@pharma_pon · X

2型糖尿病の慢性腎臓病転帰に対するフィネレノンの効果 Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes https://t.co/HoARZZwmIc

Jun 17, 2022 · 1 like · 973 followers View post →
NU Internal Medicine
@NU_IntMed · X

#NoonConference "Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes" Journal Club with Dr. Lee and content experts Dr. Jennie Lin (@jenniejlin), Dr. Anand Srivastava (@ASrivastavaMD), and Dr. Rupal Mehta (@RupalMehtaMD). https://t.co/TNL0gVVYMJ

Jun 6, 2022 · 1 like · 1 share · 5,504 followers View post →
Cheryl Lee MD (She/Her)
@kimche · X

Covering FIDELIO-DKD https://t.co/cQlWw8OWvs

Jun 3, 2022 · 1 like · 939 followers View post →
にいやん
@niiyan51 · X

Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes https://t.co/nxMKd25cn4

May 29, 2022 · 1 like · 1,074 followers View post →
ブリザード・browny
@takashi_brown · X

RT @hagi220: 今回のお題論文、このコメントとWSディスカッション結果だと大分違う印象。➝FIDELIO-DKD Investigators: Effect of Finerenone on Chronic Kidney Disease Outcomes in Typ…

Apr 24, 2022 · 1 share · 846 followers View post →
はぎ
@hagi220 · X

今回のお題論文、このコメントとWSディスカッション結果だと大分違う印象。➝FIDELIO-DKD Investigators: Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes. https://t.co/HZNtURltiq

Apr 24, 2022 · 2 likes · 1 share · 489 followers View post →
Libby Orzel
@libbysenatide · X

RT @accpcardprn: For today's #WhatsNewWednesday let’s take a

Apr 6, 2022 · 6 shares · 634 followers View post →
Fatimah Alshehri
@Banitoto · X

RT @accpcardprn: For today's #WhatsNewWednesday let’s take a

Apr 6, 2022 · 6 shares · 33,093 followers View post →
William Baker
@wbaker0621 · X

RT @accpcardprn: For today's #WhatsNewWednesday let’s take a

Apr 6, 2022 · 6 shares · 1,175 followers View post →
ACCP Cardiology PRN
@accpcardprn · X

For today's #WhatsNewWednesday let’s take a

Apr 6, 2022 · 30 likes · 6 shares · 9,300 followers View post →
Sophia Ambruso
@sophia_kidney · X

RT @ckd_ce: 38) #FIDELIO-DKD, #RCT of finerenone vs placebo in CKD outcomes in #T2D vs placebo. Primary outcome: kidney failure, sustained…

Apr 6, 2022 · 1 share · 1,973 followers View post →
@CKD_ce
@ckd_ce · X

38) #FIDELIO-DKD, #RCT of finerenone vs placebo in CKD outcomes in #T2D vs placebo. Primary outcome: kidney failure, sustained eGFR decrease > 40% or death from any renal cause, N = 5674, favored finerenone, 17.8% event rate vs 21.1% w/placebo

Apr 6, 2022 · 8 likes · 1 share · 2,636 followers View post →
Vladimir Stoyanov
@nephrospot · X

@ralcazara @SENefrologia @SOMANEorg A pesar de triplicar el riesgo de #hyperkalemia la reducción de la #mortalidadcardiovascular (RR 0.34) & all-cause mortality (RR 0.4) es algo a tener en cuenta

Apr 6, 2022 · 4 likes · 260 followers View post →
سلطان
@SultanS_Alotaib · X

@B_ALDAAJANI @sul111ksa 1) study article https://t.co/YJMri1u5xq 2) US FDA approval https://t.co/6DGJ9a42TX

Mar 15, 2022 · 2 likes · 459 followers View post →
Sophia Ambruso
@sophia_kidney · X

RT @ckd_ce: 57) #FIDELIO-DKD, #RCT of finerenone vs placebo in CKD outcomes in #T2D vs placebo. Primary outcome: kidney failure, sustained…

Feb 24, 2022 · 1 share · 1,973 followers View post →
@CKD_ce
@ckd_ce · X

57) #FIDELIO-DKD, #RCT of finerenone vs placebo in CKD outcomes in #T2D vs placebo. Primary outcome: kidney failure, sustained eGFR decrease > 40% or death from any renal cause, N = 5674, favored finerenone, 17.8% event rate vs 21.1% w/placebo

Feb 24, 2022 · 2 likes · 1 share · 2,636 followers View post →
DiabetoPitie
@DiabetoPitie · X

3/3 https://t.co/UhjZSrKgLP

Feb 22, 2022 · 1 like · 290 followers View post →
@CKD_ce
@ckd_ce · X

26) The answer is c, #finerenone.

Feb 16, 2022 · 3 likes · 2,636 followers View post →
Dr. Carlos Orellana
@orellanamd · X

RT @NefrarC: FIDELIO-DKD 5674

Feb 10, 2022 · 4 shares · 551 followers View post →
@CKD_ce
@ckd_ce · X

13) These approvals were based on results of the FIDELIO-DKD study (

Jan 19, 2022 · 11 likes · 2,636 followers View post →
Agustin Ortega
@AOrtegaCerrato · X

@MarisaNez14 @SENefrologia Antagonista no esteroideo de receptor mineralocorticoide. https://t.co/xsT3LiNHEO

Dec 5, 2021 · 409 followers View post →
Hiroyuki Sato 佐藤宏行
@foreverhero0819 · X

RT @nishiki8885: 大山先生 @kazuma_oyama より FinerenoneはほかのMRAに比べて ✔︎ MR拮抗作用が強い ✔︎ 心臓への作用が相対的に大きい ✔︎ 抗線維化作用が大きい

Nov 13, 2021 · 5 shares · 3,792 followers View post →
U40心不全ネットワーク@U40HFnetwork
@U40HF · X

RT @nishiki8885: 大山先生 @kazuma_oyama より FinerenoneはほかのMRAに比べて ✔︎ MR拮抗作用が強い ✔︎ 心臓への作用が相対的に大きい ✔︎ 抗線維化作用が大きい

Nov 13, 2021 · 5 shares · 7,442 followers View post →
Ryo Horita, MD.
@hrt01a · X

RT @nishiki8885: 大山先生 @kazuma_oyama より FinerenoneはほかのMRAに比べて ✔︎ MR拮抗作用が強い ✔︎ 心臓への作用が相対的に大きい ✔︎ 抗線維化作用が大きい

Nov 13, 2021 · 5 shares · 1,436 followers View post →
HIRO@病院薬剤師
@HIROasakatsu · X

RT @nishiki8885: 大山先生 @kazuma_oyama より FinerenoneはほかのMRAに比べて ✔︎ MR拮抗作用が強い ✔︎ 心臓への作用が相対的に大きい ✔︎ 抗線維化作用が大きい

Nov 13, 2021 · 5 shares · 255 followers View post →
高麗謙吾@心臓
@ken_korai · X

RT @nishiki8885: 大山先生 @kazuma_oyama より FinerenoneはほかのMRAに比べて ✔︎ MR拮抗作用が強い ✔︎ 心臓への作用が相対的に大きい ✔︎ 抗線維化作用が大きい

Nov 13, 2021 · 5 shares · 11,148 followers View post →
Kimitaka Nishizaki
@nishiki8885 · X

大山先生 @kazuma_oyama より FinerenoneはほかのMRAに比べて ✔︎ MR拮抗作用が強い ✔︎ 心臓への作用が相対的に大きい ✔︎ 抗線維化作用が大きい

Nov 13, 2021 · 13 likes · 5 shares · 2,947 followers View post →
Laura Ratcliffe
@lauraratcliffe7 · X

RT @HotKidneyAction: ...now FIGARO-DKD and FIDELIO-DKD show benefit in both renal and CV mortality endpoints - Rossing - #UKKW2021 https://…

Oct 7, 2021 · 1 share · 884 followers View post →
Jim Moriarty
@HotKidneyAction · X

...now FIGARO-DKD and FIDELIO-DKD show benefit in both renal and CV mortality endpoints - Rossing - #UKKW2021 https://t.co/bsKBlTN28A https://t.co/Ywv61vZLs3 https://t.co/yCtenWPL3P

Oct 7, 2021 · 1 like · 1 share · 1,100 followers View post →
みに丸
@ph_minimal · X

これか〜 Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes - PubMed https://t.co/z1tNAz1cex

Sep 8, 2021 · 2 likes · 899 followers View post →
Catherine Clase
@CMClase · X

Fidelio: https://t.co/DSw0VvLkx0 Figaro: https://t.co/2AHCfRWgxv

Sep 8, 2021 · 2,015 followers View post →
鯵ゼミ_Journal Club
@AJSR_since2005 · X

#048 Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes N Engl J Med 2020;383:2219-29.

Sep 4, 2021 · 6 followers View post →
KristopherMaday PA-C
@PA_Maday · X

FIDELIO-DKD Trial Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes https://t.co/faHjsKrJCB https://t.co/jXyjpIGsYO

Sep 2, 2021 · 2,458 followers View post →
Dr Jean Pierre Laroche #vacciné 6.0
@Echoraljpangio · X

Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes | NEJM https://t.co/RWT1MEiDtf

Aug 28, 2021 · 2,711 followers View post →
Daniel Tellez
@PharmD_Dan · X

Trial that played a large part in getting this medication approved: https://t.co/zjuQ8kYsyq

Jul 27, 2021 · 27 followers View post →
José Ant_MartínConde
@JoseMartinConde · X

RT @XBayona: "In patients with Chronic #KidneyDisease and type 2 #diabetes, treatment with #finerenone resulted in lower risks of CKD progr…

Jul 22, 2021 · 1 share · 254 followers View post →
Manu Morales Sánchez
@Manugrillo2 · X

RT @vkal29: Effect of #Finerenone on Chronic #Kidney Disease Outcomes in Type 2 #Diabetes | #NEJM https://t.co/TmqfEfbbb1

Jul 16, 2021 · 1 share · 2,140 followers View post →
Francisco Hernández
@InternumStatera · X

RT @edgarvlermamd: Effect of Finerenone on CKD Outcomes in Type 2 Diabetes ca. 2020 from @NEJM @AgarwalRajivMD @BakrisGeorge #Nephpearls…

Jul 13, 2021 · 6 shares · 83 followers View post →
Mohamed Hamedh MSc, MD
@mohamedhamedh2 · X

Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes | NEJM https://t.co/NDVwbBw3l5

Jul 12, 2021 · 1 like · 615 followers View post →
Viktor Kalashnikov
@vkal29 · X

Effect of #Finerenone on Chronic #Kidney Disease Outcomes in Type 2 #Diabetes | #NEJM https://t.co/TmqfEfbbb1

Jul 12, 2021 · 1 share · 96 followers View post →
SLU Nephrons
@slunephrons · X

RT @edgarvlermamd: Effect of Finerenone on CKD Outcomes in Type 2 Diabetes ca. 2020 from @NEJM @AgarwalRajivMD @BakrisGeorge #Nephpearls…

Jul 11, 2021 · 11 shares · 3,814 followers View post →
Letaief
@hmidato · X

RT @edgarvlermamd: Effect of Finerenone on CKD Outcomes in Type 2 Diabetes ca. 2020 from @NEJM @AgarwalRajivMD @BakrisGeorge #Nephpearls…

Jul 11, 2021 · 6 shares · 369 followers View post →
Sunil Badve
@Badves · X

RT @edgarvlermamd: Effect of Finerenone on CKD Outcomes in Type 2 Diabetes ca. 2020 from @NEJM @AgarwalRajivMD @BakrisGeorge #Nephpearls…

Jul 11, 2021 · 11 shares · 1,324 followers View post →
Saulo Fernández
@saufdez · X

RT @edgarvlermamd: Effect of Finerenone on CKD Outcomes in Type 2 Diabetes ca. 2020 from @NEJM @AgarwalRajivMD @BakrisGeorge #Nephpearls…

Jul 11, 2021 · 11 shares · 411 followers View post →
Maria Jose Glez Fa
@majogfa · X

RT @edgarvlermamd: Effect of Finerenone on CKD Outcomes in Type 2 Diabetes ca. 2020 from @NEJM @AgarwalRajivMD @BakrisGeorge #Nephpearls…

Jul 11, 2021 · 11 shares · 655 followers View post →
Dr. Carlos Orellana
@orellanamd · X

RT @edgarvlermamd: Effect of Finerenone on CKD Outcomes in Type 2 Diabetes ca. 2020 from @NEJM @AgarwalRajivMD @BakrisGeorge #Nephpearls…

Jul 11, 2021 · 6 shares · 551 followers View post →
Dr. Carlos Orellana
@orellanamd · X

RT @edgarvlermamd: Effect of Finerenone on CKD Outcomes in Type 2 Diabetes ca. 2020 from @NEJM @AgarwalRajivMD @BakrisGeorge #Nephpearls…

Jul 10, 2021 · 11 shares · 551 followers View post →
Adonay Santana
@adonay8888 · X

RT @edgarvlermamd: Effect of Finerenone on CKD Outcomes in Type 2 Diabetes ca. 2020 from @NEJM @AgarwalRajivMD @BakrisGeorge #Nephpearls…

Jul 10, 2021 · 11 shares · 148 followers View post →
Luz Marina Mejia
@LuzMarMejia · X

RT @edgarvlermamd: Effect of Finerenone on CKD Outcomes in Type 2 Diabetes ca. 2020 from @NEJM @AgarwalRajivMD @BakrisGeorge #Nephpearls…

Jul 10, 2021 · 11 shares · 402 followers View post →
Dr Tauseef Ahmed(kidney Doctor)
@ahmed_sk11 · X

RT @edgarvlermamd: Effect of Finerenone on CKD Outcomes in Type 2 Diabetes ca. 2020 from @NEJM @AgarwalRajivMD @BakrisGeorge #Nephpearls…

Jul 10, 2021 · 11 shares · 101 followers View post →
Benito Valdepenas
@Benitocept · X

RT @edgarvlermamd: Effect of Finerenone on CKD Outcomes in Type 2 Diabetes ca. 2020 from @NEJM @AgarwalRajivMD @BakrisGeorge #Nephpearls…

Jul 10, 2021 · 11 shares · 547 followers View post →
ReVolBER
@RevolberMex · X

RT @edgarvlermamd: Effect of Finerenone on CKD Outcomes in Type 2 Diabetes ca. 2020 from @NEJM @AgarwalRajivMD @BakrisGeorge #Nephpearls…

Jul 10, 2021 · 6 shares · 349 followers View post →
ReVolBER
@RevolberMex · X

RT @edgarvlermamd: Effect of Finerenone on CKD Outcomes in Type 2 Diabetes ca. 2020 from @NEJM @AgarwalRajivMD @BakrisGeorge #Nephpearls…

Jul 10, 2021 · 11 shares · 349 followers View post →
Diana Rodríguez Espinosa
@dianarodespi · X

RT @edgarvlermamd: Effect of Finerenone on CKD Outcomes in Type 2 Diabetes ca. 2020 from @NEJM @AgarwalRajivMD @BakrisGeorge #Nephpearls…

Jul 10, 2021 · 6 shares · 975 followers View post →
Edgar V. Lerma
@edgarvlermamd · X

Effect of Finerenone on CKD Outcomes in Type 2 Diabetes ca. 2020 from @NEJM @AgarwalRajivMD @BakrisGeorge #Nephpearls #VisualAbstract by @whatsthegfr https://t.co/FnhY0qQCi6 https://t.co/wyMS6AyHF3 https://t.co/OeCN7QuhS5

Jul 10, 2021 · 16 likes · 6 shares · 33,564 followers View post →
Edgar V. Lerma
@edgarvlermamd · X

Effect of Finerenone on CKD Outcomes in Type 2 Diabetes ca. 2020 from @NEJM @AgarwalRajivMD @BakrisGeorge #Nephpearls #VisualAbstract by @whatsthegfr https://t.co/FnhY0qQCi6 https://t.co/9DfF2hn1xH

Jul 10, 2021 · 36 likes · 11 shares · 33,564 followers View post →
Roberto Gutiérrez
@DrRobertoGuti · X

RT @edgarvlermamd: In patients with CKD & type 2 diabetes, treatment w/ finerenone resulted in risks of CKD progression & CV events (vs pl…

Jul 2, 2021 · 25 shares · 782 followers View post →
Letaief
@hmidato · X

RT @edgarvlermamd: In patients with CKD & type 2 diabetes, treatment w/ finerenone resulted in risks of CKD progression & CV events (vs pl…

Jul 1, 2021 · 25 shares · 369 followers View post →
Sinead Stoneman
@Stones__ · X

RT @edgarvlermamd: In patients with CKD & type 2 diabetes, treatment w/ finerenone resulted in risks of CKD progression & CV events (vs pl…

Jul 1, 2021 · 25 shares · 1,612 followers View post →
humberto_gmr
@gmr_humberto · X

RT @edgarvlermamd: In patients with CKD & type 2 diabetes, treatment w/ finerenone resulted in risks of CKD progression & CV events (vs pl…

Jul 1, 2021 · 1 share · 553 followers View post →
humberto_gmr
@gmr_humberto · X

RT @edgarvlermamd: In patients with CKD & type 2 diabetes, treatment w/ finerenone resulted in risks of CKD progression & CV events (vs pl…

Jul 1, 2021 · 25 shares · 553 followers View post →
Cam.Tran.Ngoc
@CamTranNgoc1 · X

RT @edgarvlermamd: FIDELIO-DKD and FIGARO-DKD clinical trial programs #KidneyWk

Jun 28, 2021 · 10 shares · 151 followers View post →
Dr. Michael Alexander
@MichaelAlexandp · X

RT @edgarvlermamd: @ChristosArgyrop @DrMarthaGulati FIDELIO-DKD: Effect of Finerenone on CKD Outcomes in Type 2 Diabetes ca. 2021 from @NEJ…

Jun 11, 2021 · 7 shares · 840 followers View post →
Cam.Tran.Ngoc
@CamTranNgoc1 · X

RT @edgarvlermamd: @ChristosArgyrop @DrMarthaGulati FIDELIO-DKD: Effect of Finerenone on CKD Outcomes in Type 2 Diabetes ca. 2021 from @NEJ…

Jun 11, 2021 · 7 shares · 151 followers View post →
qiengmu
@qiengmu · X

RT @edgarvlermamd: @ChristosArgyrop @DrMarthaGulati FIDELIO-DKD: Effect of Finerenone on CKD Outcomes in Type 2 Diabetes ca. 2021 from @NEJ…

Jun 11, 2021 · 7 shares · 43 followers View post →
Priyashree
@priyashreedoc · X

RT @edgarvlermamd: @ChristosArgyrop @DrMarthaGulati FIDELIO-DKD: Effect of Finerenone on CKD Outcomes in Type 2 Diabetes ca. 2021 from @NEJ…

Jun 10, 2021 · 7 shares · 36 followers View post →
Linda
@wordfinga · X

RT @edgarvlermamd: @ChristosArgyrop @DrMarthaGulati FIDELIO-DKD: Effect of Finerenone on CKD Outcomes in Type 2 Diabetes ca. 2021 from @NEJ…

Jun 10, 2021 · 7 shares · 4,594 followers View post →
Dr Anastasia Mihailidou FAHA FCSANZ FESC
@AnastasiaSMihai · X

RT @edgarvlermamd: @ChristosArgyrop @DrMarthaGulati FIDELIO-DKD: Effect of Finerenone on CKD Outcomes in Type 2 Diabetes ca. 2021 from @NEJ…

Jun 10, 2021 · 7 shares · 19,293 followers View post →
Edgar V. Lerma
@edgarvlermamd · X

@ChristosArgyrop @DrMarthaGulati FIDELIO-DKD: Effect of Finerenone on CKD Outcomes in Type 2 Diabetes ca. 2021 from @NEJM @AgarwalRajivMD @gbakris @BakrisGeorge #CKDChat #Nephpearls #VisualAbstract by @whatsthegfr https://t.co/FnhY0qQCi6 https://t.co/KvcUQeT8gG

Jun 10, 2021 · 11 likes · 7 shares · 33,564 followers View post →
Sharona Azriel
@SharonaAzriel · X

RT @sociedadSEEN:

Apr 29, 2021 · 5 shares · 1,402 followers View post →
Lilia Andrea
@LiliaAndreataf1 · X

RT @sociedadSEEN:

Apr 28, 2021 · 5 shares · 379 followers View post →
Cristina Tejera
@cristinatejerap · X

RT @sociedadSEEN:

Apr 28, 2021 · 5 shares · 11,473 followers View post →
Cristobal Morales
@CristobMorales · X

RT @sociedadSEEN:

Apr 28, 2021 · 5 shares · 17,051 followers View post →
Sociedad SEEN
@sociedadSEEN · X

Apr 28, 2021 · 12 likes · 5 shares · 17,135 followers View post →
Erik Rafflenbeul
@KardiologieHH · X

3/ FIDELIO DKD Studie präsentiert von Prof. J. Bauersachs (@JBauersachsMD; @MHHPublicHealth ) Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes (@NEJM by @BakrisGeorge) Link: https://t.co/O0iEwuv7uZ https://t.co/s0J9sEQdTe

Apr 9, 2021 · 1 like · 8,703 followers View post →
EvidenceStock
@EvidenceStock · X

RT @q0_0_: ACE阻害薬/ARB加療中の2型糖尿病合併慢性腎臓病患者(網膜症有)に対する、鉱質コルチコイド受容体拮抗薬finerenoneの腎保護効果を評価したランダム化二重盲検比較試験(FIDELIO-DKD)において、finerenoneの腎機能低下(GFR低下率…

Mar 27, 2021 · 1 share · 44 followers View post →
山本陵平
@yamamotoryohei_ · X

ACE阻害薬/ARB加療中の2型糖尿病合併慢性腎臓病患者(網膜症有)に対する、鉱質コルチコイド受容体拮抗薬finerenoneの腎保護効果を評価したランダム化二重盲検比較試験(FIDELIO-DKD)において、finerenoneの腎機能低下(GFR低下率≧40%、末期腎不全)の抑制効果が認められました。 https://t.co/O1LeZePBsl https://t.co/a4pkLcTLNB

Mar 27, 2021 · 1 share · 214 followers View post →
Nicolas Renna, MD PhD ISHF FESC
@nicolasrennamd · X

RT @ISHBP: Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes | NEJM https://t.co/rV44F7YaeO

Feb 10, 2021 · 1 share · 935 followers View post →
International Society of Hypertension
@ISHBP · X

Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes | NEJM https://t.co/rV44F7YaeO

Feb 9, 2021 · 3 likes · 1 share · 6,215 followers View post →
Metabolic Health Digest
@methealthdigest · X

Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes Read more - https://t.co/vAtDQo0O0N #diabeties #metabolicsyndrome #metabolichealthdigest #diabetesawarness #metabolichealth #diabetiesmanagement #diabetiescare #type2diabetes #kidneydiseases https://t.co/oH47a96yDf

Jan 22, 2021 · 10 followers View post →
なほ
@Ll64iiWZJL7z65L · X

Jan 12, 2021 · 33 followers View post →
Shubharthi Kar, MD, FISN
@shubharthikar · X

RT @ISNkidneycare: Live now: Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes (FIDELIO-DKD): George Bakris, MD, o…

Dec 16, 2020 · 1 share · 2,953 followers View post →
Int Society of Nephrology
@ISNkidneycare · X

Live now: Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes (FIDELIO-DKD): George Bakris, MD, on behalf of the FIDELIO Executive Committee and International investigator teams Follow our coverage through this thread.... #ISNwebinar @BakrisGeorge https://t.co/HjUIOJvrKM

Dec 16, 2020 · 12 likes · 1 share · 29,175 followers View post →
Raul Osorio
@remyosorio · X

Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes | NEJM https://t.co/4iMfPAZRTK

Dec 11, 2020 · 1 followers View post →
PubMed Trending
@PubTrend · X

Trending on PubMed: Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes. https://t.co/M4K5JPfKMO

Dec 8, 2020 · 5,163 followers View post →
irene rilo
@irilomiranda · X

RT @fikkumamoto: Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes | NEJM https://t.co/Y3e4HaUcqq

Dec 7, 2020 · 1 share · 513 followers View post →
Italo Kumamoto
@fikkumamoto · X

Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes | NEJM https://t.co/Y3e4HaUcqq

Dec 7, 2020 · 1 like · 1 share · 8,808 followers View post →
Roberto Gutiérrez
@DrRobertoGuti · X

RT @edgarvlermamd: FIDELIO-DKD: Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes ca. 2020 from @NEJM @gbakris @Ag…

Dec 7, 2020 · 1 share · 782 followers View post →
ReVolBER
@RevolberMex · X

RT @edgarvlermamd: FIDELIO-DKD: Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes ca. 2020 from @NEJM @gbakris @Ag…

Dec 6, 2020 · 2 shares · 349 followers View post →
Ahmed Tall
@ahmedtall35 · X

RT @edgarvlermamd: FIDELIO-DKD: Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes ca. 2020 from @NEJM @gbakris @Ag…

Dec 6, 2020 · 2 shares · 830 followers View post →
William Rivero
@williamrivero · X

FIDELIO-DKD: Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes ca. 2020 https://t.co/nxrXqtp4fg https://t.co/EhvLJ1RSzD

Dec 6, 2020 · 198 followers View post →
Edgar V. Lerma
@edgarvlermamd · X

FIDELIO-DKD: Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes ca. 2020 from @NEJM @gbakris @AgarwalRajivMD @P_Rossing #Nephpearls https://t.co/M7ixXTSdPh

Dec 6, 2020 · 1 like · 1 share · 33,564 followers View post →
Edgar V. Lerma
@edgarvlermamd · X

FIDELIO-DKD: Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes ca. 2020 from @NEJM @gbakris @AgarwalRajivMD #Nephpearls https://t.co/M7ixXTSdPh

Dec 6, 2020 · 8 likes · 2 shares · 33,564 followers View post →
R@gh@v
@gurda_guy · X

RT @ASPNeph: Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes #FIDELIO-DKD #CKD @NEJM https://t.co/tMFoTsxucq ht…

Dec 6, 2020 · 2 shares · 665 followers View post →
Mara Medeiros
@mmedeirosd · X

RT @ASPNeph: Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes #FIDELIO-DKD #CKD @NEJM https://t.co/tMFoTsxucq ht…

Dec 6, 2020 · 2 shares · 411 followers View post →
American Society of Pediatric Nephrology
@ASPNeph · X

Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes #FIDELIO-DKD #CKD @NEJM https://t.co/tMFoTsxucq https://t.co/Df9SZDNSHA

Dec 5, 2020 · 3 likes · 2 shares · 10,130 followers View post →
Pablo Perez Martinez
@PabloPerezMar16 · X

Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes | NEJM https://t.co/AMjbjrgwbD

Dec 5, 2020 · 3 likes · 1,302 followers View post →
the paper link
@the_paper_link · X

RT @the_paper_link: Trend new: **Bakris GL** et al (N Engl J Med) __Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabe…

Dec 4, 2020 · 1 share · 136 followers View post →
MonteNephrology
@MonteNephrology · X

Happening now.. Dr. Kaltrina Sedaliu (our outstanding second year fellow) is presenting the @NEJM paper “Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes” by George L. Bakris, M.D., et al #CKD https://t.co/WGemhMNQ0o

Dec 4, 2020 · 6 likes · 987 followers View post →
the paper link
@the_paper_link · X

Trend new: **Bakris GL** et al (N Engl J Med) __Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes__ https://t.co/OA4PB8hQNA

Dec 3, 2020 · 1 share · 136 followers View post →
Prof. Dr. Attila Nemeth PhD MBA
@anemeth1965 · X

Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes | NEJM https://t.co/t3GsddMUD6

Dec 3, 2020 · 189 followers View post →
SEMERGEN_CV
@SEMERGEN_CV · X

RT @vic_pallares: Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes | NEJM https://t.co/vhDG5CwXuv @gt_hta @jlgorr…

Dec 3, 2020 · 3 shares · 2,031 followers View post →
Cristobal Morales
@CristobMorales · X

RT @vic_pallares: Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes | NEJM https://t.co/vhDG5CwXuv @gt_hta @jlgorr…

Dec 3, 2020 · 3 shares · 17,051 followers View post →
Maarten Naesens
@mnaesens · X

Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes | NEJM https://t.co/sl7yYUxLLj

Dec 3, 2020 · 3 likes · 1,765 followers View post →
GT Diabetes Semergen
@SemergenGTDM · X

Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes | NEJM https://t.co/KHMX4udoZ8 @flopezsim @JosManceraRome1 @jescribano19 @Sonia_MJ @SorianoTrini @mpazperezunanua @glez_mohino @JOSEMANUELCOMA1 @anaolivaresloro @franjesla @laiahomedes @asimonfuentes

Dec 3, 2020 · 2 likes · 3,336 followers View post →
Gt.HTA y ECVSEMERGEN
@gt_hta · X

RT @vic_pallares: Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes | NEJM https://t.co/vhDG5CwXuv @gt_hta @jlgorr…

Dec 3, 2020 · 3 shares · 1,005 followers View post →
Vicente Pallares
@vic_pallares · X

Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes | NEJM https://t.co/vhDG5CwXuv @gt_hta @jlgorriz @SVNefro

Dec 2, 2020 · 5 likes · 3 shares · 5,425 followers View post →
Núria Montero
@nuria_montero_p · X

RT @SusanQuaggin: Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes | NEJM. When it

Nov 17, 2020 · 18 shares · 677 followers View post →
Nephrology Journal Club
@NephJC · X

A reminder #NephJC Chat in < 1hr. Discussing Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes Full text at: https://t.co/qvojiSY6CN

Nov 11, 2020 · 38,254 followers View post →
César Cano
@CsarCno · X

RT @sociedadSEEN: En @NEJM “Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes” Aleatorizado, doble ciego. n=5734.…

Nov 10, 2020 · 2 shares · 89 followers View post →
EMSA
@emsa_europe · X

3.    Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes https://t.co/8xmKfNY8gc  4.    Postpartum depression may persist three years after giving birth https://t.co/ABt2aE9t46

Nov 7, 2020 · 2,009 followers View post →
ko
@Korimoto · X

Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes | NEJM https://t.co/G0GipX8aox

Nov 4, 2020 · 365 followers View post →
Javier Escalada #Yoelijoendocrino
@fjavesc · X

RT @sociedadSEEN: En @NEJM “Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes” Aleatorizado, doble ciego. n=5734.…

Nov 2, 2020 · 2 shares · 3,620 followers View post →
Steve Hajioff
@DrSteveHajioff · X

Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes | NEJM https://t.co/TXdXfJGeXZ

Oct 30, 2020 · 667 followers View post →
a watcher
@awa19232818 · X

2020年10月29日【バイエル｜日】『フィネレノンが２型糖尿病を合併する慢性腎臓病（CKD）患者の腎および心血管系のアウトカムを有意に低減』が公開されています 非ステロイド性選択的ミネラルコルチコイド受容体拮抗 薬（MRA） https://t.co/v6rF2TIhzU https://t.co/3KyIdxevxw

Oct 29, 2020 · 417 followers View post →
Precision Diagnostics
@precisiondiagn4 · X

RT @asouth_neph: Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes | @NEJM https://t.co/JncVgLOktN #CKD #Diabetes #DiabeticKidneyDisease

Oct 29, 2020 · 1 like · 282 followers View post →
Andrew Michael South, MD, MS
@asouth_neph · X

Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes | @NEJM https://t.co/hQVyztBRZe #CKD #Diabetes #DiabeticKidneyDisease

Oct 29, 2020 · 1 like · 3,369 followers View post →
Cristina Tejera
@cristinatejerap · X

Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes | NEJM https://t.co/EYxMD4NQEe #endotwitter

Oct 28, 2020 · 2 likes · 11,473 followers View post →
Jesús Egido
@egido_jesus · X

The highly awaited publication about Finerenone and Diabetic Kidney Disease has just been published. Finerenone lowers the risk of Chronic Kidney Disease in diabetics. Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes | NEJM https://t.co/fcjwCWGY0n

Oct 28, 2020 · 154 followers View post →
Dr. Euclides Cavalcanti
@Links_Medicus · X

[Abstract Only] Randomized trial: Effect of Finerenone on chronic kidney disease outcomes in Type 2 diabetes – via @NEJM https://t.co/O7iEskDzju Commentary: https://t.co/wCjcsVybST

Oct 26, 2020 · 1 like · 29,444 followers View post →
Mugen UJIIE (氏家 無限)
@carpe_diem0820 · X

非ステロイド性の選択的ミネラルコルチコイド受容体拮抗薬で、抗炎症作用と抗線維化作用を有するフィネレノンは、2型糖尿病と慢性腎臓病の進行リスクを低下させる Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes | NEJM https://t.co/Wt4BfJJyuU https://t.co/BWzcRxYDqw

Oct 26, 2020 · 5 likes · 12,379 followers View post →
Prof AJ Jenkins
@Prof_AJ_Jenkins · X

RT @P_Rossing: Great day for people with CKD and Type 2 diabetes succes for finerenone! see our paper in NEJM Effect of Finerenone on Chro…

Oct 25, 2020 · 7 shares · 1,010 followers View post →
J Syed
@JSyed04 · X

Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes | NEJM https://t.co/oklYFFCwJW

Oct 25, 2020 · 20 followers View post →
Peter Keddis_F3_Suede
@peterkeddis1 · X

RT @SusanQuaggin: Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes | NEJM. When it

Oct 25, 2020 · 18 shares · 29 followers View post →
Jose De La Flor
@josedelaflor4 · X

Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes | NEJM https://t.co/BB98TRB4d1

Oct 25, 2020 · 456 followers View post →
Daniel Ocana Rodriguez
@danielocana2 · X

Disminución de progresión renal y eventos cardiovasculares. Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes | NEJM https://t.co/Akd0uH5E2w

Oct 25, 2020 · 1 like · 153 followers View post →
Carys Barton
@CarysBarton · X

Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes | NEJM https://t.co/uM2zyThzJi

Oct 25, 2020 · 1 like · 3,355 followers View post →
Steve Hajioff
@DrSteveHajioff · X

Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes | NEJM https://t.co/FvCn8qDodn

Oct 25, 2020 · 667 followers View post →
Jim Myers
@kidneystories · X

Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes https://t.co/zBLA0HK97E

Oct 24, 2020 · 3,482 followers View post →
Baronian Consulting
@BaronianConsult · X

Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes | NEJM https://t.co/W72cNmU2WG

Oct 24, 2020 · 1,089 followers View post →
U Bjerre-Christensen
@ulbj1 · X

RT @P_Rossing: Great day for people with CKD and Type 2 diabetes succes for finerenone! see our paper in NEJM Effect of Finerenone on Chro…

Oct 24, 2020 · 7 shares · 121 followers View post →
名前
@akkiii0830 · X

https://t.co/1CRfiKXNoz Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes FIDELIO-DKD SGLT-2iと比べてインパクトは弱い気がする。 https://t.co/CtC7yWcIG7

Oct 24, 2020 · 1 like · 247 followers View post →
Franklin Loachamin
@FranLoachamin · X

RT @Renaltubules: Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes https://t.co/J7qejds95X

Oct 24, 2020 · 1 share · 4,889 followers View post →
Ashwasena (अश्‍वसेन)
@Renaltubules · X

Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes https://t.co/J7qejds95X

Oct 24, 2020 · 13 likes · 1 share · 7,532 followers View post →
EASDelearning
@EASDelearning · X

RT @AmarPut: Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes https://t.co/RO13WMZnM7 interesting to compare to…

Oct 24, 2020 · 5 shares · 5,271 followers View post →
Manu Morales Sánchez
@Manugrillo2 · X

Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes | NEJM https://t.co/NjAR3DRxUS In patients with #CKD and type 2 diabetes, treatment with #finerenone resulted in lower risks of CKD progression and cardiovascular events than placebo. Via @NEJM

Oct 24, 2020 · 2,140 followers View post →
Alexandra Vrabie
@AlexandraVor · X

RT @SusanQuaggin: Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes | NEJM. When it

Oct 24, 2020 · 18 shares · 184 followers View post →
NANNO
@HiSoKa30M · X

NEJM: Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes RCT DM腎症（eGFR mean 44, urinary albumin mean 833）対象 Finerenone群が有意にSustained decrease of ≥40% in eGFRが低下 高Kが許容できる範囲でアルドステロン拮抗薬の使用を考慮 https://t.co/LrNYZDrDVn

Oct 24, 2020 · 79 followers View post →
Asif Sharfuddin
@graftmd · X

Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes | NEJM. Our own Dr Agarwal !! https://t.co/BTLeZDORNl

Oct 23, 2020 · 1 like · 289 followers View post →
Samira Farouk, MD, MSCR
@ssfarouk · X

RT @SusanQuaggin: Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes | NEJM. When it

Oct 23, 2020 · 18 shares · 8,543 followers View post →
青島周一@【書籍】「生成AIと学ぶ医学論文の読み方・考え方」発売中！
@syuichiao89 · X

RT @Vannyamoto: Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes | NEJM https://t.co/3AKmlhUD9p MR拮抗薬フィネレノン vs.…

Oct 23, 2020 · 1 share · 8,605 followers View post →
猫になりたい薬剤師
@Vannyamoto · X

Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes | NEJM https://t.co/3AKmlhUD9p MR拮抗薬フィネレノン vs. プラセボ 追跡期間2.6年（中央値） 主要複合アウトカム：腎不全、腎関連死亡、eGFR持続的低下 ハザード比 =0.82、95％信頼区間[CI] 0.73～0.93；P=0.001

Oct 23, 2020 · 4 likes · 1 share · 1,042 followers View post →
Jason Law
@JLawOriginal · X

RT @SusanQuaggin: Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes | NEJM. When it

Oct 23, 2020 · 18 shares · 201 followers View post →
Jennie Lin, MD MScTR
@jenniejlin.bsky.social · Bluesky

@NU_IntMed @kimche I will bring this trial (out today, with results announced at #KidneyWk) into the discussion at journal club Monday. https://www.nejm.org/doi/full/10.1056/NEJMoa2025845

Oct 23, 2020 · 1 share View post →